# Q8, Q9, and Q10 Questions and Answers (R5) – FDA Guidance

Source: https://www.keypedia.com/guidances/guidance-document/q8-q9-and-q10-questions-and-answers-r5/0d8061f0-c7e5-49c2-8e30-7202d91074f1

> FDA guidance document: Q8, Q9, and Q10 Questions and Answers (R5). Issue date: May 29, 2026. Get complete insights and analysis.

---

## Details

- Title: Q8, Q9, and Q10 Questions and Answers (R5)
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2026-05-29
- Last Changed: 2026-05-29
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-6821">FDA-2017-D-6821</a>

## Related Documents

- [M15 General Principles for Model-Informed Drug Development](https://www.keypedia.com/guidances/guidance-document/m15-general-principles-for-model-informed-drug-development/14c456d2-a084-426f-a4a8-82cdde35dc33)
- [Postapproval Pregnancy Safety Studies:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/postapproval-pregnancy-safety-studies-guidance-for-industry/cc78f1d8-dd8f-4a1d-bd04-224dab7b99ef)
- [Bioanalytical Method Validation for Biomarkers](https://www.keypedia.com/guidances/guidance-document/bioanalytical-method-validation-for-biomarkers/dc48cea7-abd8-44db-a6fc-14b002aa59d7)